Clinical outcomes associated with GLP-1 receptor agonist use in metabolic dysfunction–associated steatohepatitis
Metabolic dysfunction–associated steatohepatitis (MASH) is an important progressive liver disorder that can lead to hepatic decompensation, hepatocellular carcinoma (HCC), and premature death. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated beneficial effects on metabolic dysfunction and liver h...